Naked-Eye Bead Property Estimation
187
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}-
2-(1H-indol-3-yl)-3,4-diethoxybenzamide 10e
Acknowledgments
This work was supported by the Fonds der Chemischen
Industrie. Technical assistance of trainee Andreas Schmidt
is acknowledged.
Relative purity by HPLC: 68.2% (220 nm), 86.2% (•250 nm). (Found
•
(HRESI): [M + H]+ 485.2146. Calc. for [M + H]+ 485.2130). δH
(500 MHz; [D6]DMSO) 8.47 (1H, t, J 5.4), 8.29 (1H, br s), 8.08 (1H,
br s), 7.44 (2H, m), 7.21 (2H, br s), 6.99 (1H, d, J 8.7), 5.89 (1H, d,
J 5.5), 5.81 (2H, m), 5.48 (1H, m), 5.26 (2H, m), 4.68 (1H, m), 4.32
(1H, m), 4.10 (1H, m), 4.06 (4H, m), 3.90 (2H, m), 3.65 (1H, m), 1.33
(6H, t, J 6.7).
References
[1] C. Jamieson, M. S. Congreve, P. R. Hewitt, J. J. Scicinski, S.V. Ley,
J. Comb. Chem. 2001, 3, 397. doi:10.1021/CC010012W
[2] G. Lippens, R. Warrass, J. M. Wieruszeski, P. Rousselot-Pailley,
G. Chessari, Comb. Chem. HighThroughput Screen. 2001, 4, 333.
[3] H. U. Gremlich, Biotechnol. Bioeng. 1998, 61, 179.
[4] Y. R. de Miguel, A. S. Shearer, Biotechnol. Bioeng. 2000, 71,
119. doi:10.1002/1097-0290(2000)71:2<119::AID-BIT1003>
3.0.CO;2-R
[5] J. Mihaichuk, C. Tompkins, W. Pieken, Anal. Chem. 2002, 74,
1355. doi:10.1021/AC010884K
[6] J. J. Scicinski, M. S. Congreveb, C. Kay, S. V. Ley, Curr. Med.
Chem. 2002, 9, 2103.
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}-
2-(3,4-dichlorophenyl)acetamide 10f
Relative purity by HPLC: 99.2% (220 nm), 99.8% (•250 nm). (Found
•
(HRESI): [M + H]+ 479.1001. Calc. for [M + H]+ 479.0990). δH
(500 MHz; [D6]DMSO) 8.27 (1H, s), 8.21 (1H, t, J 5.7), 8.16 (1H,
br s), 7.44 (1H, s), 7.42 (1H, s), 7.29 (1H, t, J 8.4), 7.23 (2H, br s), 5.89
(1H, d, J 5.0), 5.82 (1H, m), 5.72 (1H, m), 5.49 (1H, d, J 5.9), 5.25 (1H,
d, J 5.5), 4.65 (1H, m), 4.32 (1H, m), 4.11 (1H, m), 3.82 (2H, s), 3.73
(2H, m).
[7] P. Rousselot-Pailley, N. J. Ede, G. Lippens, J. Comb. Chem. 2001,
3, 559. doi:10.1021/CC010019D
[8] R. S. Hutton, J. P. Adams, H. S. Trivedi, Analyst 2003, 128, 103.
doi:10.1039/B209874A
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}butyramide 10g
[9] (a) S. K. Shannon, G. Barany, J. Comb. Chem. 2004, 6, 165.
doi:10.1021/CC034033X
Relative purity by HPLC: 92.5% (220 nm), 95.6% (•250 nm). (Found
•
(HRESI): [M + H]+ 545.1083. Calc. for [M + H]+ 545.1102). δH
(b) F. Gaggini, A. Porcheddu, G. Reginato, M. Rodriquez,
M.Taddei, J. Comb. Chem. 2004, 6, 805. doi:10.1021/CC049963A
[10] J. J. Cournoyer, T. Kshirsagar, P. P. Fantauzzi, G. M. Figliozzi,
T. Makdessian, B.Yan, J. Comb. Chem. 2002, 4, 120. doi:10.1021/
CC010060G
[11] J. Vazquez, F. Albericio, Tetrahedron Lett. 2001, 42, 6691.
doi:10.1016/S0040-4039(01)01372-7
[12] E. Kaiser, R. L. Colescott, C. D. Bossinger, P. I. Cook, Anal.
Biochem. 1970, 34, 595. doi:10.1016/0003-2697(70)90146-6
[13] V. Krchnák, J. Vágner, P. Šafár, M. Lebl, Collect. Czech. Chem.
Commun. 1988, 53, 2542.
(500 MHz; [D6]DMSO) 8.29 (1H, br s), 8.15 (1H, br s), 8.20 (1H, t,
J 5.6), 7.54 (1H, d, J 2.7), 7.33 (1H, dd, J 6.2 and 2.7), 7.25 (2H, br s),
7.14 (1H, d, J 9.0), 5.89 (1H, d, J 5.2), 5.79 (1H, m), 5.69 (1H, m), 5.50
(1H, m), 5.27 (1H, m), 4.66 (1H, m), 4.30 (1H, m), 4.10 (1H, m), 4.05
(2H, t, J 6.4), 3.71 (2H, q, J 5.2), 2.29 (2H, t, J 7.2), 1.95 (2H, m).
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}-
3,5-difluorobenzamide 10h
Relative purity by HPLC: 97.2% (220 nm), 92.9% (•250 nm). (Found
•
(HRESI): [M + H]+ 433.1436. Calc. for [M + H]+ 433.1460). δH
[14] (a) J. Rademann, M. Barth, Angew. Chem., Int. Ed. 2002,
41, 2975. doi:10.1002/1521-3773(20020816)41:16<2975::AID-
ANIE2975>3.0.CO;2-N
(500 MHz; [D6]DMSO) 8.81 (1H, m), 8.28 (1H, br s), 8.06 (1H, br s),
7.55 (1H, m), 7.43 (1H, t, J 4.4), 7.21 (2H, br s), 5.88 (2H, m), 5.79
(1H, m), 5.46 (1H, m), 5.26 (1H, m), 4.69 (1H, m), 4.33 (1H, m), 4.10
(1H, m), 3.92 (2H, m).
(b) M. Barth, J. Rademann, J. Comb. Chem. 2004, 6, 340.
doi:10.1021/CC034041D
[15] B. J. Backes, A. A. Virgilio, J. A. Ellman, J. Am. Chem. Soc. 1996,
118, 3055. doi:10.1021/JA9535165
[16] J. K. Cho, P. D. White, W. Klute, T. W. Dean, M. Bradley, Chem.
Commun. 2004, 502. doi:10.1039/B315426B
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}-
3-methylbutyramide 10i
Relative purity by HPLC: 78.5% (220 nm), 83.5% (•250 nm). (Found
[17] S. Meenakshisundaram, R. Sockalingam, Collect. Czech. Chem.
Commun. 2001, 66, 897. doi:10.1135/CCCC20010897
[18] E. B. Melnikov, G. A. Suboch, E.Y. Belyaev, Russ. J. Org. Chem.
1995, 31, 1640.
[19] P. Malatesta, B. Lotti, Ann. Chim. 1960, 50, 114.
[20] C. Herforth, J.Wiesner, S. Franke,A. Golisade, H. Jomaa,A. Link,
J. Comb. Chem. 2002, 4, 302. doi:10.1021/CC0100823
[21] C. Lerner, B. Masjost, A. Ruf, V. Gramlich, R. Jakob-Roetne,
G. Zurcher, E. Borroni, F. Diederich, Org. Biomol. Chem. 2003,
1, 42. doi:10.1039/B208690P
[22] A. Golisade, J. C. Bressi, S.Van Calenbergh, M. H. Gelb,A. Link,
J. Comb. Chem. 2000, 2, 537. doi:10.1021/CC0000343
[23] C. Herforth, J. Wiesner, P. Heidler, S. Sanderbrand, S. Van
Calenbergh, H. Jomaa, A. Link, Bioorg. Med. Chem. 2004, 12,
755. doi:10.1016/J.BMC.2003.11.008
[24] B. Yan, L. Fang, M. Irving, S. Zhang, A. M. Boldi, F. Woolard,
C. R. Johnson, T. Kshirsagar, G. M. Figliozzi, C. A. Krueger,
N. Collins, J. Comb. Chem. 2003, 5, 547. doi:10.1021/CC030008F
•
(HRESI): [M + H]+ 399.1757. Calc. for [M + H]+ 399.1784). δH
(500 MHz; [D6]DMSO) 8.25 (1H, br s), 8.13 (1H, br s), 7.89 (1H, t,
J 5.5), 7.21 (1H, br s), 5.87 (1H, d, J 4.8), 5.71 (2H, m), 4.63 (1H, t,
J 4.81), 4.29 (1H, t, J 5.7), 4.09 (1H, t, J 5.0), 3.68 (2H, m), 0.99 (2H,
d, J 6.4), 0.84 (7H, m).
N-{(E)-3-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-
3,4-dihydroxytetrahydrofuran-2-yl]prop-2-enyl}cyclohex-
2-ene-carboxylic Acid Amide 10j
Relative purity by HPLC: 97.7% (220 nm), 95.4% (•250 nm). (Found
•
(HRESI): [M + H]+ 401.1937. Calc. for [M + H]+ 401.1961). δH
(500 MHz; [D6]DMSO) 8.28 (1H, br s), 8.15 (1H, br s), 7.91 (1H, m),
7.26 (2H, br s), 5.89 (1H, d, J 5.0), 5.73 (2H, m), 5.65 (2H, br s), 5.47
(1H, m), 5.24 (1H, m), 4.66 (1H, m), 4.31 (1H, m), 4.11 (1H, m), 3.70
(2H, m), 2.34 (1H, m), 2.09 (1H, m), 2.03 (3H, m), 1.75 (1H, m), 1.51
(1H, m).
HPLC profiles of compounds 10a–10j at 250 and 220 nm
are available from the author or, until February 2010, the
Australian Journal of Chemistry.